Prolonged Progression-Free Survival with Partial Disease Regression in Advanced Metastatic Medullary Thyroid Carcinoma Treated with Vandetanib by Sravanthi Sanivarapu, MD, Zahily Sardiñas, MD, Salini C. Kumar, MD, David S. Rosenthal, MD, Wondwossen Gebre, MD, Minakshi Ramchand, MD

Get full text